Literature DB >> 2188388

Juvenile arthritis and uveitis.

J J Kanski1.   

Abstract

The association between juvenile arthritis and uveitis is reviewed. Some children with the HLA-B27 related spondyloarthropathies develop anterior uveitis. About 20% of patients with juvenile rheumatoid arthritis (JRA) who are negative for IgM rheumatoid factor develop a frequently bilateral, nongranulomatous chronic anterior uveitis. Risk factors for uveitis in JRA patients are: female gender, pauciarticular onset of arthritis, presence of circulating antinuclear antibodies, and the antigens HLA-DW5 and HLA-DPw2. Uveitis is rare after seven years or more have elapsed from the onset of arthritis. The visual prognosis in patients with uveitis is good in 25% and fair in 50%. The remaining 25% develop visual impairment from complicated cataract and/or secondary inflammatory glaucoma. The potential benefit of cytotoxic agents in the treatment of intractable uveitis is outweighed by the risk of serious side effects. The management of secondary inflammatory glaucoma is unsatisfactory, but the results of treatment of complicated cataracts by lensectomy-vitrectomy are good.

Entities:  

Mesh:

Year:  1990        PMID: 2188388     DOI: 10.1016/0039-6257(90)90026-r

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  28 in total

1.  Recurrent hypopyon in chronic anterior uveitis of pauciarticular juvenile idiopathic arthritis.

Authors:  J H Chang; P J McCluskey; J R Grigg
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

2.  Cataract extraction and intraocular lens implantation in children with uveitis.

Authors:  A Lundvall; C Zetterström
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

3.  Ocular involvement in children with localised scleroderma: a multi-centre study.

Authors:  Maria Elisabetta Zannin; Giorgia Martini; Balu H Athreya; Ricardo Russo; Gloria Higgins; Fabio Vittadello; Maria Giannina Alpigiani; Mariolina Alessio; Mauro Paradisi; Patricia Woo; Francesco Zulian
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

4.  Persisting uveitis antedating psoriasis in two boys.

Authors:  Marinka Twilt; Marietta Swart van den Berg; Jan C van Meurs; Rebecca ten Cate; Lisette W A van Suijlekom-Smit
Journal:  Eur J Pediatr       Date:  2003-07-03       Impact factor: 3.183

5.  Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.

Authors:  Anthony C Gregory; John H Kempen; Ebenezer Daniel; R Oktay Kaçmaz; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne
Journal:  Ophthalmology       Date:  2012-10-11       Impact factor: 12.079

Review 6.  Treatment of ocular inflammation in children.

Authors:  Sunil M Thadani; C Stephen Foster
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Juvenile idiopathic arthritis-associated uveitis: Data from a region in western Greece.

Authors:  Ioannis Asproudis; Taxiarchis Felekis; Elena Tsanou; Spiridon Gorezis; Eikaterini Karali; Sapfo Alfantaki; Antigoni Siamopoulou-Mauridou; Miltiadis Aspiotis
Journal:  Clin Ophthalmol       Date:  2010-04-26

8.  Uveitis and juvenile idiopathic arthritis: A cohort study.

Authors:  David BenEzra; Evelyne Cohen; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2007-12

9.  Adalimumab for juvenile idiopathic arthritis-associated uveitis.

Authors:  Adriano Magli; Raimondo Forte; Pasqualina Navarro; Giustina Russo; Francesca Orlando; Loredana Latanza; Maria Alessio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-01       Impact factor: 3.117

10.  The Association of Race With Childhood Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Curtis Travers; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Am J Ophthalmol       Date:  2015-08-06       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.